Retraction: MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance By Targeting A20/NF-κB Signaling Pathway
- PMID: 30389812
- DOI: 10.1158/1535-7163.MCT-18-0938
Retraction: MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance By Targeting A20/NF-κB Signaling Pathway
Retraction of
-
MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.Mol Cancer Ther. 2017 Oct;16(10):2094-2106. doi: 10.1158/1535-7163.MCT-17-0385. Epub 2017 Jul 11. Mol Cancer Ther. 2017. Retraction in: Mol Cancer Ther. 2018 Nov;17(11):2490. doi: 10.1158/1535-7163.MCT-18-0938. PMID: 28698199 Retracted.
Publication types
LinkOut - more resources
Full Text Sources
